MELINTA THERAPEUTICS, INC. /NEW/ Selling, General and Administrative Expense
MELINTA THERAPEUTICS, INC. /NEW/ reported Selling, General and Administrative Expense of $26.42 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2019-11-12
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for the quarter ending 2019-09-30 was $26.42M, a 22.95% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for the quarter ending 2019-06-30 was $30.93M, a 11.49% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for the quarter ending 2019-03-31 was $25.94M, a 25.08% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for the quarter ending 2018-12-31 was $29.45M, a 21.14% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for fiscal 2018 was $133.31M, a 110.52% increase from fiscal 2017.
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for fiscal 2017 was $63.33M, a 226.25% increase from fiscal 2016.
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for fiscal 2016 was $19.41M, a 37.09% increase from fiscal 2015.
- MELINTA THERAPEUTICS, INC. /NEW/ selling, general and administrative expense for fiscal 2015 was $14.16M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $26.42M 10-Q · filed 2019-11-12 | $57.35M derived: sum of 2 quarters · filed 2019-11-12 | $83.29M 10-Q · filed 2019-11-12 | $112.75M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $30.93M 10-Q · filed 2019-08-09 | $56.87M 10-Q · filed 2019-08-09 | $86.33M derived: sum of 3 quarters · filed 2019-08-09 | $120.61M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-03-31 | $25.94M 10-Q · filed 2019-05-10 | $55.40M derived: sum of 2 quarters · filed 2019-05-10 | $89.68M derived: sum of 3 quarters · filed 2019-11-12 | $124.63M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-12-31 | $29.45M 10-K · filed 2019-03-14 | $63.74M derived: sum of 2 quarters · filed 2019-11-12 | $98.69M derived: sum of 3 quarters · filed 2019-11-12 | $133.31M 10-K · filed 2019-03-14 |
| 2018-09-30 | $34.29M 10-Q · filed 2019-11-12 | $69.23M derived: sum of 2 quarters · filed 2019-11-12 | $103.86M 10-Q · filed 2019-11-12 | $141.21M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $34.95M 10-Q · filed 2019-08-09 | $69.57M 10-Q · filed 2019-08-09 | $106.92M derived: sum of 3 quarters · filed 2019-08-09 | $117.22M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $34.62M 10-Q · filed 2019-05-10 | $71.97M derived: sum of 2 quarters · filed 2019-05-10 | $82.28M derived: sum of 3 quarters · filed 2019-05-10 | $89.98M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $37.35M 10-K · filed 2019-03-14 | $47.65M derived: sum of 2 quarters · filed 2019-03-14 | $55.35M derived: sum of 3 quarters · filed 2019-03-14 | $63.33M 10-K · filed 2019-03-14 |
| 2017-09-30 | $10.30M 10-K · filed 2019-03-14 | $18.00M derived: sum of 2 quarters · filed 2019-03-14 | $25.98M 10-Q · filed 2018-11-07 | $30.56M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $7.70M 10-K · filed 2019-03-14 | $15.67M 10-Q · filed 2018-08-09 | $20.26M derived: sum of 3 quarters · filed 2019-03-14 | $24.37M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $7.97M 10-K · filed 2019-03-14 | $12.56M derived: sum of 2 quarters · filed 2019-03-14 | $16.67M derived: sum of 3 quarters · filed 2019-03-14 | $21.62M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $4.59M 10-K · filed 2018-03-16 | $8.70M derived: sum of 2 quarters · filed 2018-03-16 | $13.65M derived: sum of 3 quarters · filed 2018-03-16 | $19.41M 10-K · filed 2019-03-14 |
| 2016-09-30 | $4.11M 10-K · filed 2018-03-16 | $9.06M derived: sum of 2 quarters · filed 2018-03-16 | $14.82M derived: sum of 3 quarters · filed 2018-03-16 | |
| 2016-06-30 | $4.95M 10-K · filed 2018-03-16 | $10.71M derived: sum of 2 quarters · filed 2018-03-16 | ||
| 2016-03-31 | $5.76M 10-K · filed 2018-03-16 | |||
| 2015-12-31 | $14.16M 10-K · filed 2018-03-16 |